Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy

被引：0
|
作者：
Pace, L. [1 ]
Klain, M. [1 ]
Soricelli, A. [2 ]
Albanese, C. [1 ]
Salvatore, B. [1 ]
Storto, G. [3 ]
Salvatore, M. [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Univ Parthenope, Naples, Italy
[3] CNR, IBB, I-80125 Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [21] The care of patients receiving iodine 131 for the treatment of thyroid cancer
    Williams, E
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1454 - 1454
  • [22] A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatment
    Azizmohammadi, Zahra
    Tabei, Faraj
    Shafiei, Babak
    Babaei, Ali Akbar
    Jukandan, Seyed Mohsen Qutbi
    Naghshine, Reza
    Javadi, Hamid
    Nabipour, Iraj
    Assadi, Majid
    Asli, Isa Neshandar
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2013, 16 (02): : 103 - 106
  • [23] Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
    Han, Ji Min
    Kim, Won Bae
    Yim, Ji Hye
    Kim, Won Gu
    Kim, Tae Yong
    Ryu, Jin-Sook
    Gong, Gyungyub
    Sung, Tae-Yon
    Yoon, Jong Ho
    Hong, Suck Joon
    Kim, Eui Young
    Shong, Young Kee
    THYROID, 2012, 22 (08) : 784 - 790
  • [24] Initial activity-related long-term outcome of iodine-131 treatment for thyroidectomy patients with differentiated thyroid carcinoma
    Hung, Mao-Chin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (03): : 246 - 250
  • [25] High therapeutic dosages of radioiodine in differentiated thyroid cancer patients with detectable serum thyroglobulin.
    de Keizer, B
    de Klerk, JM
    Koppeschaar, HP
    Zelissen, PM
    Lips, CM
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 308P - 308P
  • [26] Serum thyroglobulin in evaluating the response to 131I treatment in patients with distant metastatic differentiated thyroid cancer
    慕转转
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 130 - 131
  • [27] Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases
    Filesi, M
    Signore, A
    Ventroni, G
    Melacrinis, FF
    Ronga, G
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1542 - 1546
  • [28] Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer
    Kloos, Richard T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05): : 1519 - 1525
  • [29] Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment
    Yi, Wook
    Kim, Bo Hyun
    Kim, Mijin
    Ryang, So Ree
    Jang, Min Hee
    Kim, Jeong Mi
    Kim, Eun Heui
    Jeon, Yun Kyung
    Kim, Sang Soo
    Kim, In Joo
    ENDOCRINE JOURNAL, 2020, 67 (12) : 1193 - 1198
  • [30] Does the dosimetric study with 124-Iodine match the real pharmacokinetic of 131-Iodine during therapy of metastatic Differentiated Thyroid Cancer?
    Rossi, G.
    Ancidei, S.
    Barucca, S.
    Berbellini, A.
    Capoccetti, F.
    Ferretti, F.
    Manni, C.
    Nicoli, P. S.
    Palucci, A.
    Poggiu, A.
    Fattori, S.
    Brianzoni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S200 - S201
12345